Minerva Financial Statements From 2010 to 2024
UTRSDelisted Stock | USD 0.26 0.00 0.00% |
Check Minerva Surgical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Minerva Surgical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Minerva financial statements analysis is a perfect complement when working with Minerva Surgical Valuation or Volatility modules.
Minerva |
Minerva Surgical Company Return On Equity Analysis
Minerva Surgical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Minerva Surgical Return On Equity | -1.6 |
Most of Minerva Surgical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Minerva Surgical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Minerva Surgical has a Return On Equity of -1.6008. This is 93.32% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Minerva Surgical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Minerva Surgical's current stock value. Our valuation model uses many indicators to compare Minerva Surgical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Minerva Surgical competition to find correlations between indicators driving Minerva Surgical's intrinsic value. More Info.Minerva Surgical is rated third in return on equity category among its peers. It is rated second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Minerva Surgical's earnings, one of the primary drivers of an investment's value.About Minerva Surgical Financial Statements
Minerva Surgical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Minerva Surgical investors may analyze each financial statement separately, they are all interrelated. The changes in Minerva Surgical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Minerva Surgical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company was incorporated in 2008 and is headquartered in Santa Clara, California. Minerva Surgical operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 157 people.
Thematic Opportunities
Explore Investment Opportunities
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Minerva Pink Sheet
If you are still planning to invest in Minerva Surgical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Minerva Surgical's history and understand the potential risks before investing.
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |